Pulmonx Corp
NASDAQ:LUNG
Pulmonx Corp
NASDAQ:LUNG
Price:
9.82 USD
4.69%
Updated:
May 6, 2024
Pulmonx Corp
Cash from Financing Activities
|
Pulmonx Corp
Cash from Financing Activities Peer Comparison
Comparables:
COO
XRAY
ALGN
LNTH
Competitive Cash from Financing Activities Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Cash from Financing Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Pulmonx Corp
NASDAQ:LUNG
|
Cash from Financing Activities
$21.4m
|
CAGR 3-Years
-55%
|
CAGR 5-Years
12%
|
CAGR 10-Years
N/A
|
|
|
Cooper Companies Inc
NYSE:COO
|
Cash from Financing Activities
$116m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
DENTSPLY SIRONA Inc
NASDAQ:XRAY
|
Cash from Financing Activities
-$307m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
-4%
|
CAGR 10-Years
-7%
|
|
|
Align Technology Inc
NASDAQ:ALGN
|
Cash from Financing Activities
-$598.3m
|
CAGR 3-Years
-129%
|
CAGR 5-Years
-13%
|
CAGR 10-Years
-34%
|
|
|
Lantheus Holdings Inc
NASDAQ:LNTH
|
Cash from Financing Activities
-$13.1m
|
CAGR 3-Years
16%
|
CAGR 5-Years
-23%
|
CAGR 10-Years
N/A
|
See Also
What is Pulmonx Corp's Cash from Financing Activities?
Cash from Financing Activities
21.4m
USD
21.4m
USD
Based on the financial report for Dec 31, 2023, Pulmonx Corp's Cash from Financing Activities amounts to 21.4m USD.
What is Pulmonx Corp's Cash from Financing Activities growth rate?
Cash from Financing Activities CAGR 5Y
12%
12%
Over the last year, the Cash from Financing Activities growth was 784%. The average annual Cash from Financing Activities growth rates for Pulmonx Corp have been -55% over the past three years , 12% over the past five years .
You don't have any saved screeners yet
